Polymorphism of <em>CYP3A4</em> and <em>ABCB1</em> genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.